PPARG and Alzheimer disease: This observation aligns with molecular docking results, which predicted stronger affinity of THPOC for ALB and CASP3, and a preference for PM38 in PPARG, reinforcing the complementary nature of both ligands in targeting distinct AD-related proteins.